Tumor transplants in mice for better personalized medicine

by Biocat

What Xenopat does is implant human tumors into the same organ they are originally from: lung tumors into the mouse’s lungs, ovarian tumors into its ovaries, thus avoiding the issue for the most part...

Read more

A new and less toxic HIV drug

by IBEC - Institut de Bioenginyeria de Catalunya

The new drug, called tenofovir alafenamide does not generate long-term toxicity in the tissues of patients with HIV since it is not metabolized in the blood, but does so directly into lymphoid cells

Read more

Evidence of the importance of telomeres in plant stem cells

by CNIO - Centro Nacional de Investigaciones Oncológicas

It presents the possibility of using plants to look for compounds capable of regulating the telomeres in animal cells that could be useful in the treatment of illnesses associated with ageing, includi...

Read more

European project to develop an innovative therapeutic strategy against epilepsy

by IRB Barcelona - Instituto de Investigación Biomédica

There is increasing evidence that proteins in the extracellular matrix (ECM) play a fundamental role in neural development and regeneration, synaptic plasticity, neuronal excitability and neural netwo...

Read more

Study describes phenomenon of resistance to novel therapy for advanced lung cancer

by Vall d’Hebron

According to the Spanish Association Against Cancer, around 20,000 cases are diagnosed each year in Spain, representing 18.4% of all tumors in men - 18,000 cases - and 3.2% in women - 2,000 cases -.

Read more

Diseñan un tratamiento nuevo contra la candidiasis bucal, una de las enfermedades más frecuentes en pacientes inmunodeprimidos

by Universitat de Barcelona

El estudio ha permitido obtener un sistema antifúngico con las mejores características con el que mantener los niveles terapéuticos durante un período de tiempo más largo

Read more

IrsiCaixa researchers prove that HIV uses a family of immune system cells as a "Trojan horse" to spread out the infection

by IrsiCaixa

Scientists from IrsiCaixa AIDS Research Institute, jointly promoted by the Obra Social "la Caixa" and the Health Department of the Generalitat de Catalunya, have proved that a family of immune system ...

Read more

Nuevos fármacos mejoran el pronóstico de las enfermedades inflamatorias intestinales

by Instituto de Investigación Sanitaria La Fe

La enfermedad inflamatoria intestinal es una dolencia crónica, progresiva y que genera una gran discapacidad. La importancia de avanzar en la investigación de nuevos tratamientos queda de relieve en...

Read more

Un estudio demuestra que la combinación de dos nuevos anticuerpos podría ser más eficaz como tratamiento del cáncer colorrectal avanzado

by Vall d’Hebron

El estudio muestra una tasa de control de la enfermedad del 67% y apunta que los anticuerpos de Sym004 consiguen una penetración superior y, por tanto, mejores resultados que el cetuximab o el panitu...

Read more

IrsiCaixa prepares the start of clinical trials of therapeutic AIDS vaccine

by IrsiCaixa

The therapeutic vaccine designed by IrsiCaixa researchers is the very first one developed according to the immune response of people who control HIV without antiretroviral treatment. Phase I trials wi...

Read more

La inmunoterapia, eficaz también en cáncer de pulmón

by ICO - Institut Català d'Oncologia

Un estudio con participación del ICO Badalona que publica The New England Journal of Medicine muestra que el 19% de los pacientes con cáncer de pulmón responden a la inmunoterapia

Read more

INPACT, un proyecto internacional para el desarrollo preclínico de fármacos innovadores

by UPF - Universitat Pompeu Fabra

El presupuesto global para este proyecto es de un millón de euros y tendrá una duración de cuatro años, a contar a partir del 1 de febrero de 2015

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

A chip against chronic bacterial infecti...

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC researchers develop a device that allows to grow biofilms and ana...

Photos Stream